A good way to see where this article is headed is to take a look at the screen shot of a demo program shown in Figure 1. The demo sets up a dummy dataset of six items: [ 5.1 3.5 1.4 0.2] [ 5.4 3.9 1.7 ...

A phase 1 study of PARP inhibitor (niraparib) plus HSP90 inhibitor (pimitespib) in solid tumors: Dose-expansion results from the NiraPim (EPOC2102) study. Genomic landscape of 5’methylthioadenosine ...

Automated Extraction of Tumor Staging and Diagnosis Information From Surgical Pathology Reports Prostate cancer (PCa) is among the leading causes of cancer deaths. While localized PCa has a 5-year ...